News & Events

Covid-19 pandemic : Biomatlante continues its activity

: Biomatlante News; 18 March 2020

Nantes, France, March 18, 2020

Dear Partner,

In this new context of fighting the spread of the Covid-19 virus, Biomatlante has adapted its organization in order to ensure the continuity of its services to support you in your activity.

Cyril d’Arros receives an award for his oral presentation at Bioceramics31

: Biomatlante News; 04 December 2019

Congratulations from Biomatlante team!

BIOMATLANTE joins the AMS Group

: Biomatlante News; 03 December 2019

Biomatlante is very pleased to announce the acquisition of 100% of its shares by Advanced Medical Solutions Group plc (London Alternative Investment Market: AMS).

Biomatlante: a new step towards the MDR

: Biomatlante News; 03 July 2019

Just after BSI last January, TÜV Süd Product Service GmbH is now the second Notified Body designated to issue CE Marking certifications under the European Medical Devices Regulation (MDR).

Biomatlante receives MDSAP Accreditation

: Biomatlante News; 06 March 2019

Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the obtention of the MDSAP^* accreditation on the new ISO 13485:2016 Certificate.

BIOMATLANTE announces the appointment of its new CEO

: Biomatlante News; 01 February 2019

Julien Dert named as new CEO of Biomatlante, Chantal Gobin continues as Chairman of the Board

Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the appointment of its new CEO, Julien Dert, being effective on February 1st, 2019.